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INTRODUCTION
Kawasaki disease, first described by Dr. Tomisaku Kawasa-
ki in Japan in 1967, is acute febrile vasculitis in childhood
characterized by prolonged fever, polymorphous skin rash,
non-purulent conjunctivitis, oral mucositis, erythematous
induration of extremities, and cervical lymphadenopathy (1).
The differential diagnosis includes scarlet fever, toxic shock
syndrome, measles, drug reaction, viral infection and other
vasculitis syndromes. It can be difficult to differentiate from
other acute febrile illnesses, because of some clinical and epi-
demiologic features support an infectious origin. From the
histopathological aspects, Kawasaki disease is vasculitis in
the small and medium-sized blood vessels (2, 3), similar to
Henoch-Schonlein purpura, which is the most commonly
encountered vasculitis syndrome in childhood. Especially, the
interaction between leukocytes and vascular endothelial cells
contributes to pathogenesis of these diseases (4, 5). So it is
important to understand the factors that may recruit and acti-
vate leukocytes to the regions of vasculitis in both diseases.
Chemokine is one of the most important factors in this
process (6). Recently, many studies in vestigated chemokines
to understand the factors that may recruit and activate leuko-
cytes to the regions of vasculitis in several diseases (7-11).
In the present study, we compared the production of three
chemokines; interferon- -inducible protein-10 (IP-10), mono-
cyte chemoattractant protein-1 (MCP-1) and growth-related
oncogene- (Gro- ) in peripheral blood from patients with
Kawasaki disease, Henoch-Schonlein purpura and other acute
febrile illnesses, which overlap each other in some clinical or
pathological findings.
MATERIALS AND METHODS
Study population
All patients were prospectively evaluated at the Depart-
ment of Pediatrics, Yeungnam University Hospital, Daegu,
Korea, between February 2001 and May 2003. The patients
were composed of three groups: the first group included 29
patients (16 males and 13 females; mean age, 2.43 yr, range
6 months to 7 yr) at the acute febrile stage of Kawasaki dis-
ease. The second group included 15 patients (11 males and
4 females; mean age, 6.07 yr, range 2 to 14 yr) at the acute
stage of Henoch-Schonlein purpura. The third group includ-
ed 12 patients (6 males and 6 females; mean age, 3.4 yr, range
1 month to 8 yr) at the acute febrile stage of illnesses, such as
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Production of Chemokines in Kawasaki Disease, Henoch-Schonlein
Purpura and Acute Febrile Illness
We compared the production of three chemokines; interferon- -inducible protein-
10 (IP-10), monocyte chemoattractant protein-1 (MCP-1) and growth-related onco-
gene- (Gro- ) that attracts monocytes or neutrophils, or both, in peripheral blood
at acute stage of Kawasaki disease (n=29), Henoch-Schonlein purpura (n=15) and
acute febrile illnesses (n=12). The production of the chemokines was assayed by
ELISA. The plasma levels of IP-10 were markedly elevated in Kawasaki disease
(538.6±336.4 pg/mL) and acute febrile illnesses (417.1±262.2 pg/mL) compared
with in Henoch-Schonlein purpura (58.7±95.7 pg/mL) (p<0.05). The MCP-1 levels
were elevated in Kawasaki disease (443.0±473.1 pg/mL) and acute febrile illnesses
(328.6±261.1 pg/mL) compared with in Henoch-Schonlein purpura (82.9±79.0
pg/mL) (p<0.05). The Gro- levels were elevated only in acute febrile illnesses
(134.3±153.6 pg/mL) compared with in Kawasaki disease (31.8±22.1 pg/mL) or
Henoch-Schonlein purpura (29.4±53.3 pg/mL) (p<0.05). According to these results,
monocytes may play an important role in Kawasaki disease. In acute febrile illness-
es, both monocytes and neutrophils may play an important role. By contrast, Henoch-
Schonlein purpura may not be associated with the role of monocytes and neutrophils.
Further studies using a larger number of cases are needed.
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measles (3 cases), acute gastroenteritis (2), pneumonia (2),
pharyngotonsillitis (2), and one each case of mumps, exan-
them subitum, and urinary tract infection (Table 1).
Sampling
Peripheral blood sample (5 mL) were drawn from the pati-
ents at acute stage, and were centrifuged at 2,000 rpm/min
for 30 min. Plasma samples were frozen at -70℃ for the
ELISA assay.
ELISA assay
ELISAs for IP-10, MCP-1 and GRO- were performed
according to the manufacturer’s instruction using the kits
from the R&D systems (Minneapolis, MN, U.S.A.). Briefly,
standards and patient plasma were incubated in anti-human
IP-10 (or MCP-1 or Gro- ) coated plates, 100  L per well,
at room temperature for 2 hr. Then the plates were further
incubated with 200  L of prepared biotinylated antibody at
room temperature for 1 hr, and then 200  L of tetramethyl-
benzidine substrate solution was added for development in
darkness at room temperature for 20 min. The reaction was
stopped by adding of 50  L of stop solution. The absorbance
was measured at 450 nm for IP-10, MCP-1 and GRO- .
Statistical analysis
Data were expressed as mean±standard deviation. The
significance of differences was assessed by the Mann-Whitney
test. A p-value<0.05 was considered significant.
RESULTS
Plasma levels of IP-10 
The plasma levels of IP-10 were markedly elevated in the
patients with Kawasaki disease (538.6±336.4 pg/mL) and
those with acute febrile illnesses (417.1±262.2 pg/mL) com-
pared with in the Henoch-Schonlein purpura group (58.7±
95.7 pg/mL) (p<0.05) (Table 1, Fig. 1). There was no statis-
tical significance between Kawasaki disease and acute febrile
illnesses.
Plasma levels of MCP-1
The MCP-1 plasma levels were elevated in the patients
with Kawasaki disease (443.0±473.1 pg/mL) and those with
acute febrile illnesses (328.6±261.1 pg/mL) compared with
Henoch-Schonlein purpura group (82.9±79.0 pg/mL) (p<
0.05) (Table 2, Fig. 2). In addition, the plasma levels of MCP-
1 were not elevated in 8 patients with Kawasaki disease, with
less than 100 pg/mL. 
Plasma levels of Gro-
The Gro- levels were elevated only in the patients with
acute febrile illnesses (134.3±153.6 pg/mL) (Table 2, Fig.
3). As in the MCP-1, the Gro- level was extremely low in
2 patients with pharyngotonsillitis among the patients with
acute febrile illnesses with 3.12 pg/mL and 6.10 pg/mL, re-
spectively.
DISCUSSION
The chemokine (chemotactic cytokine) is a large family of
cytokines composed of small pro-inflammatory peptides that
regulate trafficking, activation and proliferation of myeloid,
lymphoid, melanocytes, and vascular endothelial cells. The
chemokines are divided into four groups; C, C-C, C-X-C and
C-X3-C, based on the number of amino acids between the
first two cysteines (6).
The selective attraction of leukocytes in response to chemo-
kines may be determined by the expression of specific chemo-
kine receptors on their cell surface. For example, neutrophils
express receptors for C-X-C chemokines, but not for C-C che-
mokines. In general, C-X-C chemokines attract neutrophils,
but not monocytes, while C-C chemokines do the reverse (6).
The chemokine IP-10 is the only member of C-X-C che-
mokines that attracts monocytes and T lymphocytes. The IP-
10 secretion has been detected in macrophages, endothelial
cells, keratinocytes and activated T cells in response to a num-
ber of activating stimuli, such as IFN- and TNF . IP-10 is
involved in delayed type hypersensitivity and participates in
the pathogenesis of infection and shock, such as acute Lassa
fever (10), and canine endotoxemia (11). In addition, it has
been shown to be associated with inflammatory responses of
immune-mediated diseases, such as rheumatoid arthritis, graft
KD, Kawasaki disease; HSP, Henoch-Schonlein purpura; AFI, Acute
febrile illnesses.
KD HSP AFI
Case (No.) 29 15 12
Sex (M/F) 16/13 11/4 6/6
Age (range) 2.43 yr (6 m-7 yr) 6.07 yr (2-14 yr) 3.14 yr (1 m-8 yr)
Table 1. The characteristics of study group
. .
KD, Kawasaki disease; HSP, Henoch-Schonlein purpura; AFI, Acute
febrile illnesse.
KD HSP AFI
IP-10 538.6±336.4 58.7±95.7 417.1±262.2
MCP-1 443.0±473.1 82.9±79.0 328.6±261.1
Gro- 31.8±22.1 29.4±53.3 134.3±153.6
Table 2. The plasma level of chemokines (pg/mL)
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rejection and tuberculosis. In the present study, the plasma
level of IP-10 was markedly elevated in Kawasaki disease
and acute febrile illnesses compared with Henoch-Schonlein
purpura.
The chemokine MCP-1, a member of the C-C family of
chemokines, attracts monocytes and lymphocyte, but not
neutrophils (12-15). MCP-1 has been involved to elicit degran-
ulation and respiratory burst in monocytes and cytokine pro-
duction in these cells. In this regard, MCP-1 has been called
as monocyte chemotactic and activating factor (MCAF). MCP-
1 is also a potent histamine-releasing agent since it attracts
monocytes that secrete supernatants, containing histamine
release factors. In this study, MCP-1 was elevated in the pa-
tients with Kawasaki disease and acute febrile illnesses com-
pared with in the Henoch-Schonlein purpura group. How-
ever, the plasma levels of MCP-1 were not elevated consis-
tently. In 8 cases of Kawasaki disease, the MCP-1 levels were
below 100 pg/mL. Further studies incorporating a larger
number of cases are needed.
Gro- is a member of C-X-C chemokines that attracts neu-
trophils, monocytes, basophils and lymphocytes. Gro- con-
tributes to the ongoing inflammatory process and neutrophil
infiltration associated with various diseases (8, 16-22). In
the present study, Gro- was elevated only in acute febrile
illnesses compared with in Kawasaki disease and Henoch-
Schonlein purpura.
The interaction between leukocytes and vascular endothe-
lial cells contributes to the pathogenesis of Kawasaki disease.
This immune activation accompanied by elevated levels of
various pro-inflammatory cytokines. Increased production
of tumor necrosis factor  (TNF- ), interleukin (IL)-1 , IL-2,
interferon (IFN)- , IL-6, IL-8, RANTES, MCP-1, macro-
phage inflammatory protein-1 ‚ (MIP-1 ) and IP-10 has been
detected in peripheral blood of patients with Kawasaki dis-
ease (4, 7, 8, 22-25).
Henoch-Schonlein purpura is one of the vasculitis disorders
with rash, arthritis, abdominal pain and renal involvements
(26). Although Henoch-Schonlein purpura has been suggest-
ed to represent an immunoglobulin A related immune com-
plex disease, the pathogenesis has not been fully elucidated.
Acute inflammation in Henoch-Schonlein purpura manifests
as leukocytoclastic vasculitis on light microscopy. Although
the factors that determine and mediate the severity of Henoch-
Schonlein purpura remain poorly understood, proinflamma-
tory cytokines such as IL-1, IL-6 and TNF- (27-30) may
be involved. Besbas et al. (28) demonstrated that TNF- and
IL-1 levels are high in the acute phase of Henoch-Schonlein
purpura. Wu et al. (29) also demonstrated that TNF- and
IL-1 levels were high in Henoch-Schonlein purpura glomeru-
lonephritis.
Many pro-inflammatory cytokines such as IL-1, IL-6, IL-8,
TNF- and IP-10 are involved in the pathogenesis of other
febrile processes (7, 10, 31-34). Cha et al. observed the ele-
vated levels of IL-6 on stimulation of Candida albicans (33).
Valbuena et al. also detected elevation of MCP-1 in response
to the infection of spotted fever group rickettsiae (34). We
also observed Gro- was elevated in measles, mumps and other
viral infections. Interestingly, however,  Gro- was extremely
low in 2 patients with pharyngotonsillitis among the acute
febrile illnesses. Regrettably, the causative organisms in the
patients with pharyngotonsillitis were not identified.
In conclusion, during the acute stage of Kawasaki disease,
the IP-10 and MCP-1 levels were elevated. IP-10, MCP-1
and Gro- were elevated during the other acute febrile ill-
nesses. By contrast, none of these chemokines were elevated
in Henoch-Schonlein purpura. According to these results,
monocytes may play an important role in Kawasaki disease.
In other acute febrile illnesses, both monocytes and neutrophils
may play an important role. Henoch-Schonlein purpura may
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Fig. 1. The chemokine IP-10 levels in plasma. KD, Kawasaki dis-
ease; HSP, Henoch-Schonlein purpura; AFI, Acute febrile illnesses.
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Fig. 3. The chemokine Gro- levels in plasma. KD, Kawasaki dis-
ease; HSP, Henoch-Schonlein purpura; AFI, Acute febrile illnesses.
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Fig. 2. The chemokine MCP-1 levels in plasma. KD, Kawasaki dis-
ease; HSP, Henoch-Schonlein purpura; AFI, Acute febrile illnesses.
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not be associated with the role of monocytes and neutrophils.
Further studies are needed to define the clear relationship
between the chemokines and neutrophils in these illnesses.
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